Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
Bayer
Karyopharm Therapeutics Inc
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Institute of Cancer Research, United Kingdom
SEED Therapeutics, Inc.